EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib

EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 4,354 citations, 2004 year and green oa status.